RDIF and Mubadala complete an investment in healthcare in the Moscow Region
Press release, 24.08.2017
Moscow, 24 August 2017 - The Russian Direct Investment Fund (RDIF), Mubadala Development Company and other leading Middle Eastern funds announce the closure of a deal to invest in the construction, launch and maintenance of oncology and radiotherapy medical centres in the cities of Balashikha and Podolsk in the Moscow region.
The project will be accomplished via the concession agreement between the Moscow Region Government and project specific companies. The centres’ construction and operational completion is expected in the near future.
Following the successful launch of the project the centres expect to run approximately 25,000 diagnostic tests and 5,000 operations annually for the treatment of oncological diseases. The use of the latest medical equipment will expand the ability of medical personnel and improve the quality of medical services in the Moscow region, including those covered by the Compulsory Health Insurance programme.
Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF), said:
"Top Middle Eastern investors were attracted by the unique project structure, which made this investment in important social services in Russia, such as medicine, very appealing. We are confident that this investment with our co-investors will help boost the quality of medical services for patients, and hope that the doors of these centres will be open in the foreseeable future. "
Russian Direct Investment Fund (RDIF) is Russia's sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy. RDIF’s management company is based in Moscow. Further information can be found at www.rdif.ru
For additional information contact:
Russian Direct Investment Fund
Tel: +7 495 644 34 14, ext. 2395
Mobile: +7 916 110 31 41
Andrew Hayes / Yulianna Vilkos
Tel: +44 (0) 20 7796 4133